PBI vertical.jpg
Uncle Bud’s Health and Wellness to Expand New Premium Collection with Novel Products for Sleep, Memory, Pain, Immunity, Feminine Hygiene, and Sexual Wellness
11 avr. 2024 10h52 HE | Pressure BioSciences, Inc.
PBIO’s UltraShear Platform Enables Development and Launch of Health & Wellness Products with Revolutionary Bioavailability, Onset, and Effectiveness
CBD Body Revive Spray
Pressure BioSciences’ Uncle Bud’s Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection”
02 avr. 2024 10h19 HE | Pressure BioSciences, Inc.
PBIO's Uncle Bud’s Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection
PBI vertical.jpg
Pressure BioSciences Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing
15 févr. 2024 10h52 HE | Pressure BioSciences, Inc.
PBIO's Relocation Delivers Substantially Increased Manufacturing Space, Improved Operating Efficiencies, and Cost Savings for Unencumbered Growth
CBD Body Revive Spray
Uncle Bud’s to Launch New Premium Health and Wellness Products Leveraging Pressure BioSciences UltraShear Processing for Revolutionary Product Effectiveness
05 févr. 2024 08h23 HE | Pressure BioSciences, Inc.
Pressure BioSciences February 5th Investor Call to Discuss Recent Uncle Buds Acquisition
UltraShear CBD Body Revive Spray
Pressure BioSciences Upcoming Investor Call to Discuss Recent Acquisition of Uncle Buds
01 févr. 2024 08h59 HE | Pressure BioSciences, Inc.
Uncle Bud’s 2024 Revenue Expected to Increase 3-Fold to Approximately $5 Million, Fueled by UltraShear Processed Nanoemulsion Product Introductions
Toni Braxton
Pressure BioSciences’ New Consumer Products Unit Continues Long Sales Relationship with Dominant U.S. Retailer, Launching 2024 with Quarter Million Dollar Shipment in January
16 janv. 2024 08h47 HE | Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a pioneer in the development and distribution of broadly enabling...
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21 juil. 2022 18h00 HE | ProPhase Labs, Inc.
Garden City, NY, July 21, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that it has granted an inducement stock option...
Pressure BioSciences’ PCT Platform Featured in Multiple Presentations at Major International Science Conference
26 sept. 2019 09h29 HE | Pressure BioSciences, Inc.
   Ten Presentations by Scientists from Seventeen Research Institutions Worldwide  Highlight Novel Applications for PBI’s PCT Platform in Cancer Research and Diagnostics South Easton, MA,...
Pressure BioSciences Prepares for Growth, Adding Daniel J. Shea as Chief Financial Officer 
17 sept. 2019 10h33 HE | Pressure BioSciences, Inc.
Shea’s 30-Year Diverse Experience in Acquisitions, Capital Markets, SEC Reporting, and Leading Financial Organizations Bolsters PBI’s Strong Senior Management Team South Easton, MA, Sept. 17,...
Pressure BioSciences’ PCT Platform Identified as Pivotal for Cancer Biomarker Discovery and for Potential Clinical Diagnostics
10 sept. 2019 09h33 HE | Pressure BioSciences, Inc.
Two Prestigious Research Centers Report PBI’s PCT Platform Delivers Superior Results for Protein Biomarker Discovery Studies from Preserved Cancer Biopsy Tissue Samples SOUTH EASTON, MA,...